Stocks and Investing
Stocks and Investing
Mon, December 4, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, December 1, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Patrick Trucchio Reiterated (ALT) at Strong Buy and Held Target at $15 on, Dec 1st, 2023
Patrick Trucchio of HC Wainwright & Co., Reiterated "Altimmune, Inc." (ALT) at Strong Buy and Held Target at $15 on, Dec 1st, 2023.
Patrick has made no other calls on ALT in the last 4 months.
There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Patrick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Patrick
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $8 on, Thursday, November 9th, 2023
Contributing Sources